Medical Patent Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Behavior
New behavior study findings have been reported by M.A. Salinger and co-researchers
January 25th, 2008
According to recent research from the United States, "Economics at the Federal Trade Commission (FTC) supports both the competition and consumer protection missions of the agency. In this year's essay we discuss two issues, one from each of the agency's missions." "First, we focus on intellectual property issues in pharmaceuticals. Specifically, we discuss the principal rationale for antitrust concerns about certain patent dispute settlements in the ethical drug industry," wrote M.A. Salinger and colleagues. The researchers concluded: "Then, we discuss consumer economics, our recent behavioral economics conference, and how behavioral economics...
Source: Medical Patent Business Week (2008-01-25)
|